1. Home
  2. CTXR vs FENG Comparison

CTXR vs FENG Comparison

Compare CTXR & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

N/A

Current Price

$0.54

Market Cap

18.7M

Sector

Health Care

ML Signal

N/A

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

N/A

Current Price

$1.40

Market Cap

18.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CTXR
FENG
Founded
2007
1998
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
18.7M
18.1M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
CTXR
FENG
Price
$0.54
$1.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 175.6K
2.2K
Earning Date
08-14-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 43.38
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$104.18
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$1.39
52 Week High
$2.19
$2.89

Technical Indicators

Market Signals
Indicator
CTXR
FENG
Relative Strength Index (RSI) 48.00 39.45
Support Level $0.55 N/A
Resistance Level $0.61 $1.52
Average True Range (ATR) 0.03 0.02
MACD -0.00 -0.00
Stochastic Oscillator 49.88 7.78

Price Performance

Historical Comparison
CTXR
FENG

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives all of its revenue from PRC.

Share on Social Networks: